Showing session: reset
Has Pandora's Box Been Opened? The Site-agnostic Approval of Pembrolizumab
- Sort by:
- Browse by:
- Free
- slides video
- audio + slides
- All slides included
Chairperson
Steven J. Lemery
U.S. Food and Drug Administration, Silver Spring, MD, United States
- Free
- slides video
- audio + slides
- All slides included
Invited Speaker
Janaki Veeraraghavan
U.S. Food and Drug Administration, Silver Spring, MD, United States
- Free
- slides video
- audio + slides
- All slides included
Invited Speaker
Russell R Broaddus
UT MD Anderson Cancer Ctr., Houston, TX, United States
- Free
- audio + slides
- Some slides withheld
Invited Speaker
Heather L. Hampel
The Ohio State University Comprehensive Cancer Center, Columbus, OH, United States
Presentation given by
Russell R Broaddus
UT MD Anderson Cancer Ctr., Houston, TX, United States
- Free
- slides video
- audio + slides
- All slides included
Invited Speaker
Michael J Overman
UT MD Anderson Cancer Ctr., Houston, TX, United States
- Free
- slides video
- audio + slides
- All slides included
Invited Speaker
Zsofia K. Stadler
Memorial Sloan Kettering Cancer Center, New York, NY, United States
- Free
- audio + slides
- All slides included
Panel Discussion
Steven J. Lemery
U.S. Food and Drug Administration, Silver Spring, MD, United States
Janaki Veeraraghavan
U.S. Food and Drug Administration, Silver Spring, MD, United States
Russell R Broaddus
UT MD Anderson Cancer Ctr., Houston, TX, United States
Michael J Overman
UT MD Anderson Cancer Ctr., Houston, TX, United States
Zsofia K. Stadler
Memorial Sloan Kettering Cancer Center, New York, NY, United States